Valuation: American Shared Hospital Services

Market Cap 10.04M 8.78M 8.1M 7.49M 14.22M 958M 14.46M 96.97M 38.01M 470M 37.68M 36.86M 1.63B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 10.04M 8.78M 8.1M 7.49M 14.22M 958M 14.46M 96.97M 38.01M 470M 37.68M 36.86M 1.63B EV / Sales 2026 *
0.34x
EV / Sales 2027 * -
Free-Float
65.29%
Yield 2026 *
-
Yield 2027 * -
1 day+3.06%
1 week+1.68%
Current month-4.11%
1 month+1.00%
3 months+13.91%
6 months-30.37%
Current year-28.20%
1 week 1.41
Extreme 1.41
1.57
1 month 1.36
Extreme 1.36
1.74
Current year 1.25
Extreme 1.25
2.39
1 year 1.25
Extreme 1.25
3.11
3 years 1.25
Extreme 1.25
4.6
5 years 1.25
Extreme 1.25
4.6
10 years 0
Extreme 0
5.04
Manager TitleAgeSince
Chief Executive Officer 72 2026-04-26
Director of Finance/CFO 54 2024-12-18
Sales & Marketing - 2023-01-31
Director TitleAgeSince
Chairman 68 2023-03-06
Director/Board Member 74 2015-12-31
Director/Board Member 69 2021-12-27
Date Insider Type Main position Quantity % Market Cap.
03-25Other

Chairman

100,000 1.5225%
25-06-25Other

Chairman

110,000 1.7134%
25-04-29Free

Chief Executive Officer

5,613 0.0874%
Change 5-day change 1-year change 3-year change Capi.($)
+3.06%+1.68%-37.91%-40.44% 9.74M
+1.60%-0.90%+35.41%+151.09% 67.13B
+3.84%+0.91%+13.09%+14.56% 28.8B
-3.50%-16.62% - - 4.18B
+3.42%+7.37%+0.19%+3.96% 4.68B
-0.23%+3.32%+25.29%+102.79% 3.97B
+0.93%-2.82%-4.33%+26.59% 2.79B
+2.08%-0.53%+65.87%+455.39% 1.55B
-0.45%-4.34%-58.55%-24.10% 1.29B
+0.39%-0.58%+55.66%+120.80% 994M
Average +1.11%-3.84%+10.52%+90.07% 11.54B
Weighted average by Cap. +1.94%-1.21%+26.30%+106.64%

Financials

2026 *2027 *
Net sales 29.95M 26.2M 24.16M 22.35M 42.43M 2.86B 43.14M 289M 113M 1.4B 112M 110M 4.86B -
Net income - -
Net Debt - -
Logo American Shared Hospital Services
American Shared Hospital Services is a provider of turn-key technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services. Its segments include Leasing and Retail. The Leasing segment comprises the Company’s medical equipment leasing. The Retail segment comprises facilities in Peru and Ecuador. Its Proton Beam Radiation Therapy Operations is an alternative to traditional external beam, photon-based radiation delivered by linear accelerators. Its Gamma Knife stereotactic radiosurgery, a non-invasive procedure, is an alternative to conventional brain surgery and/or radiation therapy. The Gamma Knife treats selected malignant and benign brain tumors, arteriovenous malformations, and functional disorders including trigeminal neuralgia (facial pain). It can be an adjunct to conventional brain surgery, radiation therapy, or chemotherapy. The Company provides radiation therapy services both domestically and internationally.
Employees
83
Date Price Change Volume
26-07-09 US$1.515 +3.06% 72,456
26-07-08 US$1.470 0.00% 97,259
26-07-07 US$1.470 -4.55% 77,678
26-07-06 US$1.540 +3.36% 44,325
26-07-02 US$1.490 -1.32% 49,095

Quarterly revenue - Rate of surprise